Pulmonary Function Testing Systems Market Overview 2019:
As per latest data released by Market Research Future (MRFR), the global market for pulmonary function testing (PFT) systems will exhibit a strong CAGR of 8.20% CAGR from 2018 to 2023.
Tests involved in assessing pulmonary function are non-invasive and mainly performed to identify respiratory issues. In recent years, issues related to respiration has increased to a substantial level partly due to factors such as climate change, rising air pollution and increased consumption of cigarette. PFT systems are used for measuring lung volume, capacity, the rate of flow and gas exchange. The information derived from the test are accurate and help in diagnosing certain lung disorders as well as determining treatment or therapeutics for them.
Get Sample Copy for this Report at https://www.marketresearchfuture.com/sample_request/6603
Global Pulmonary Function Testing Systems Market: Competitive Landscape
Some of the prominent players that are currently operating in the market include COSMED srl, Schiller, CHEST M.I.,Inc, Diagnostic Corporation, Vyaire Medical, Inc, Medical Equipment Europe GmbH, ECO MEDICS AG, ndd Medical Technologies, Medical Electronic Construction and MGC
The report offers insights on the leading market players and evaluates their current market share. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives.
Global Pulmonary Function Testing Systems Market: Segmental Analysis
By Type
- Complete PFT Systems
- Portable PFT Systems
Test Type
- Spirometry
- Lung Volume
- Gas Exchange Testing
- Maximal Voluntary Ventilation
- Oxygen Titration Test
- High Altitude Simulation Testing
By Component
- Software
- Hardware
- Service
By Application
- Chronic Obstructive Pulmonary Disease
- Asthma
- Chronic Shortness of Breath
- Restrictive Lung Disease
By End-User
- Hospital/Clinical Laboratories
- Diagnostics Laboratories
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/pulmonary-function-testing-systems-market-6603
Global Pulmonary Function Testing Systems Market: Regional Analysis
In the report, the pulmonary function testing systems market has been covered across regions such as North America, the Middle East & Africa (MEA), South America, Europe and Asia Pacific (Asia Pacific). The market in Americas is most lucrative and also makes a considerable contributes in terms of revenue. In 2017, the Americas collectively accounted for 39.0% market share followed by Europe and Asia-Pacific with 31.9% and 21.1% market share respectively.
Pulmonary function testing (PFT) is an important diagnostic and management tool which is used to evaluate the respiratory system in cases of asthma, chronic pulmonary diseases, disability, and several others. The global pulmonary function testing (PFT) systems market is on an upward trend and is anticipated to grow at a CAGR of 8.20% during the forecast period from 2018 to 2023. In 2017, the market was valued at USD 2409.3 Mn and is expected to generate revenue to reach an estimated USD 3,865.9 Mn by the end of 2023.
Pulmonary Function Testing Systems Market Latest Updates
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.